Starpax Investment Opportunity Tackling 90% of Cancers!

Enter a New World of Cancer Treatment.................................................................................

Unsubscribe Starpax Biopharma Inc. has officially launched a Regulation A capital raise to finance its clinical trials on humans. The technology is conceived to tackle a major resistance problem for cancer treatments and bring hope to patients and their families worldwide.  (By clicking the link above, you are opting in to receive emails from this advertiser. You are also agreeing to the terms of our privacy policy. Unsubscribe at any time) Read on to learn more about Starpax's revolutionary technology and the opportunity to invest. Studies have shown that roughly 90% of the volume of a tumor receives little to no medication when it comes to current systemic cancer treatments. Starpax Biopharma is set to address the US$901 billion solid tumor treatment market by creating the cancer treatment of the future with its never-before-seen Precision 3D Guidance Therapy, including Starpax Living Magnetodronesô and PolarTrak® technology. Reduced risk of failure and shortened expected FDA reviews. According to the FDA, 97% of clinical trials with new drugs fail, posing a substantial financial risk to investors. Since Starpax Technology is conceived to use anti-cancer molecules that are already FDA-approved and have been used in humans for years, investors face a lower risk of failure. Additionally, Starpax addresses six of the most common cancers simultaneously, increasing the number of patients available for clinical trials compared to single rare drug trials. Starpax also meets the criteria of the FDA Fast Track Program and Health Canada accelerated review standards. Both factors will speed up Starpax's trials and approvals. Living Magnetodrones, Artificial Intelligence, and Patented Magnetic Fields to treat cancer. With conventional systemic treatments, 90% of the tumor receives little or no drug due to malfunctioning and collapsed blood vessels in tumors. Starpax Living Magnetodrones are conceived to distribute drugs into the tumor without using blood vessels and can penetrate and accumulate in hypoxic zones. Hypoxic zones are key to treating cancer since that's where the cancer stem cells are located, but they can't be reached by current conventional drugs or immune cells. The PolarTrak device in which the patient is placed is conceived to use its patented magnetic fields, controlled by Starpax's AI technology, to trap the Magnetodrones transporting drugs inside the tumor and force them to spread throughout. Preclinical tests have resulted in a 100% remission rate in extremely aggressive tumors without any toxicity observed.  Business model built to scale rapidly. Starpax has engaged specialized firms in the U.S. to find the best commercial solutions to reach patients as fast as possible. The business model involves starting the deployment of 25 Starpax Cancer Treatment Centers (of the 580 needed in the U.S.) within seven years, with a forecasted EBITDA of US$348 million in Year 2 and US$12 billion in Year 7 upon FDA approval. Starpax's technology is set to revolutionize cancer care and improve the lives of patients worldwide. Be part of a mission to create a world where cancer treatment is more effective, safe and accessible. Invest today (By clicking the link above, you are opting in to receive emails from this advertiser. You are also agreeing to the terms of our privacy policy. Unsubscribe at any time) The Starpax Team This message is a PAID ADVERTISEMENT for Starpax from Interactive Offers. StockEarnings, Inc receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $1300. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either Starpax or Interactive Offers. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Starpax on Starpax website for additional information about the relationship between Interactive Offers and Starpax. Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click Unsubscribe. StockEarnings, Inc 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA W: 877.6.STOCKS StockEarnings.com Today's Bonus Content: Central Bank Gold Heist In Progress!

The lithium stock you should be watching this year

Unsubscribe Demand for lithium is skyrocketing. Early effects of the coming supply crunch are being felt today - with the price of lithium shooting up nearly 6x. The lithium price has recently retreated into oversold territory due to supply momentarily catching up, providing investors with a compelling entry point to gain exposure to a market that is expected to continuing surging. By 2025, demand is expected to outstrip supply by a multiple of 15 times. By 2040, global demand for lithium is expected to grow 4,000% from today. Thankfully a series of new discoveries across North America are offering hope that lithium shortages can be avoided. In particular, is an early-stage lithium explorer, Canter Resources (CSE:CRC, OTC:CNRCF) with a promising project in one of the world's most favorable jurisdictions - Clayton Valley, Nevada. The region is home to the only producing lithium mine in the United States - Silver Peak, owned and operated by Albemarle... As well as high potential projects from American Battery Technology and Ioneer - both the recent recipients of federal funding. The best part is, this junior was staked by the same team that discovered both American Battery Technology and Ioneers primary resources, among several others. In fact, with this teams claims also being developed by American Lithium, Pure Energy, and Schlumberger, this same team has been responsible for over $1 billion in market value. Find out how this under $1 explorer could be at the forefront of the next great lithium success story.   Tomorrow Investor

This email was sent to stevenmagallanes520.nims@blogger.com by editor@marketmovingtrends.com MarketMovingTrends c/o CLM Media LLC, 45 South Park Place, #203, Morristown, NJ 07960 United States   Unsubscribe | Report Spam

GAIN Reports from March 25, 2024

The following GAIN reports were released on March 25, 2024. _______   China: 47 National Food Safety Standards Released On March 12, 2024, the People's Republic of China (PRC) National Health Commission (NHC) and State Administration for Market Regulation (SAMR) jointly published an Announcement on releasing 47 new or updated National Food Safety Standards (known as Guo Jia Biao Zhun, or GB Standards) and 6 amendments sheets. The new or updated GB standards cover food additives, nutritional fortification substances, milk powder, food contact materials, microbial testing methods, and testing for arsenic and nickel. This report provides an unofficial translation of the Announcement. Stakeholders should conduct their own review of the regulations. India: Walks like a Duck and Quacks like a Duck - We Have US Grade A Duck in India On February 22, 2024, India's Ministry of Fisheries, Animal Husbandry and Dairying/Department of Animal Husbandry and Dairying, issued Office Memorandum File No. L-110109(3)/1/2016-Trade (E-2625) outlining the parameters for premium frozen duck meat for import into India. On March 6, 2024, the Ministry of Commerce and of Industry/Department of Commerce - Directorate General of Foreign Trade, authorized imports of premium frozen duck meat for into India under the harmonized tariff system (HS) codes 0207.4200 and 0207.4500. Concurrently, on March 6, 2024, the Ministry of Finance/Department of Revenue notified the lowering of import duties for premium frozen duck meat and the governing conditions for imports via the Notification No. 13/2024-Customs. Exports of U.S.-origin premium frozen duck meat to India are foreseen to accelerate in the short-to-mid-term. Sri Lanka: Sri Lanka Extends Implementation of Food Trans - Fats Regulation 2022 by One Year The Democratic Socialist Republic of Sri Lanka's (Sri Lanka) Ministry of Health extended the implementation effective date of the Food (Trans Fat) Regulations (2022) from January 1, 2024 to January 1, 2025. The Sri Lankan government notified the extension in the Gazette of the Democratic Socialist Republic of Sri Lanka – Extraordinary (official gazette) on December 27, 2023.   For more information, or for an archive of all FAS GAIN reports, please visit gain.fas.usda.gov/. Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit subscriberhelp.govdelivery.com. This service is provided to you at no charge by USDA Foreign Agricultural Service. This email was sent to stevenmagallanes520.nims@blogger.com using GovDelivery Communications Cloud on behalf of: USDA Foreign Agricultural Service · 1400 Independence Avenue, SW · Washington, DC 20250

This week, Tim Cook just opened Apple's (AAPL) newest store... in China. The tech giant is currently facing what could be one of the biggest antitrust lawsuits in history. Yet its CEO was halfway around the world taking care of business.

Apple's CEO Is Fighting Hard to Win This Market... And It's Not the U.S. By Vic Lederman, editorial director, Chaikin Analytics This week, Tim Cook just opened Apple's (AAPL) newest store... in China. The tech giant is currently facing what could be one of the biggest antitrust lawsuits in history. Yet its CEO was halfway around the world taking care of business. Cook wasn't in China just to grace the opening of Apple's second-largest store worldwide – and its 57th in China... He was there to make sure Apple didn't lose any more ground... in what recently became the company's biggest single market for iPhones. You see, Apple ended 2023 on a high note. It had a leading 17%-plus share of China's smartphone market last year. But iPhone sales in the country plunged 24% year over year ("YOY") in just the first six weeks of 2024. That kind of YOY decline for a massive brand like Apple – in a smartphone market that only fell by 7% from the previous year – is unheard of. Meanwhile, Chinese tech giant Huawei saw its market share nearly double in a year to near 17%. And as Apple's sales plunged at the beginning of this year, Huawei's sales popped 64%. Taken together, Huawei looks like it has already surpassed Apple as China's largest smartphone vendor so far this year... Recommended Links: Here's What You Missed Yesterday A rare mathematical inversion in ONE corner of the stock market now presents a 1-in-20-year money-making opportunity we may never see again in our lifetime. It has nothing to do with "The Magnificent Seven" or the presidential election... and doesn't involve trading options or bitcoin. Yet, it could create enormous wealth for those who position themselves correctly, beginning today. Click here to tune in now. The sneaky (yet 100% legal) way for Obama to return to power The ONLY way Democrats can keep the White House is to bring back Barack Obama. And there's a sneaky (yet 100% legal) way to achieve this. In fact, this disaster scenario is already underway. See what they're up to, and how you can get ready today. Here's the full video exposé. That's impressive. Just a year ago, Huawei wasn't even able to produce high-end smartphones. U.S. sanctions had prevented it from buying advanced microchips. So this massive change likely alarmed Cook. It's a rise he hasn't seen since Apple first released its iPhone almost 17 years ago. Folks, the reality is that the U.S. smartphone market suffers from a lack of competition. It's practically an oligopoly. Apple has an incredible 62% share of the market, while Samsung has a 17% share. The third-largest-selling brand – with a 9% share – is owned by Chinese brand Lenovo. But in the U.S., it mostly sells Motorola-branded smartphones. Lenovo acquired the business a decade ago. That means other brands have just a combined 12% share. Again, Apple has a dominant position in the U.S. This is largely why the U.S. Department of Justice believes the company is violating antitrust laws. But Apple's U.S. dominance hasn't helped in China. The company constantly fluctuates from first place to third place in China's enormous smartphone market. Apple doesn't completely dominate there like it does in the U.S. In China, Apple faces big and capable competition coming from all corners. Keep in mind that many of China's best homegrown smartphone brands – and Apple's toughest competitors in the country – aren't available for public consumption in the U.S. They're either banned outright (like Huawei) or must go through steep approvals to get cleared for domestic sale. That ultimately means fewer choices for American consumers and less competition for Apple. And unless the U.S., Mexico, or even India become smartphone-manufacturing powerhouses overnight, Apple can't help but remain at the top in the U.S. That's why Cook would rather be in China this week. He has a big reason to be paying attention to his company's efforts there. Good investing, Vic Lederman Market View Major Indexes and Notable Sectors     # Hld:     Bullish     Neutral     Bearish Dow 30 -0.02% 12 17 1 S&P 500 -0.18% 186 248 63 Nasdaq -0.32% 39 49 11 Small Caps -0.2% 487 1029 391 Bonds +0.28% — According to the Chaikin Power Bar, Large Cap stocks and Small Cap stocks are Bullish. Major indexes are mixed. *  *  *  * Sector Tracker Sector movement over the last 5 days Discretionary +0.99% Communication +0.87% Industrials +0.81% Financial +0.8% Materials +0.75% Energy +0.39% Information Technology +0.14% Health Care -0.01% Staples -0.36% Utilities -0.56% Real Estate -1.19% *  *  *  * Industry Focus Bank Services 56 31 4 Over the past 6 months, the Bank subsector (KBE) has outperformed the S&P 500 by +2.78%. Its Power Bar ratio, which measures future potential, is Very Strong, with more Bullish than Bearish stocks. It is currently ranked #5 of 21 subsectors. Top Stocks NTRS Northern Trust Corpo BPOP Popular, Inc. BK The Bank of New York *  *  *  * Top Movers Gainers MKC +10.52% STX +7.38% WDC +4.88% MGM +4.29% DPZ +3.85% Losers UPS -8.16% IP -6.49% APA -4.94% F -3.57% NRG -3.3% *  *  *  * Earnings Report Reporting Today Rating Before Open After Close JEF CCL, CTAS, CNM RH No earnings reporting today. Earnings Surprises MKC McCormick & Company, Incorporated Q1 $0.63 Beat by $0.06 NCNO nCino, Inc. Q4 $0.21 Beat by $0.09 PRGS Progress Software Corporation Q1 $1.25 Beat by $0.11 *  *  *  * You have received this e-mail as part of your subscription to PowerFeed. If you no longer want to receive e-mails from PowerFeed, click here. You're receiving this e-mail at STEVENMAGALLANES520.NIMS@BLOGGER.COM. For questions about your account or to speak with customer service, call +1 (877) 697-6783 (U.S.), 9 a.m. - 5 p.m. Eastern time or e-mail info@chaikinanalytics.com. Please note: The law prohibits us from giving personalized investment advice. © 2024 Chaikin Analytics, LLC. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Chaikin Analytics, LLC. 201 King Of Prussia Rd., Suite 650, Radnor, PA 19087. www.chaikinanalytics.com. Any brokers mentioned constitute a partial list of available brokers and is for your information only. Chaikin Analytics, LLC, does not recommend or endorse any brokers, dealers, or investment advisors. Chaikin Analytics forbids its writers from having a financial interest in any security they recommend to our subscribers. All employees of Chaikin Analytics, LLC (and affiliated companies) must wait 24 hours after an investment recommendation is published online – or 72 hours after a direct mail publication is sent – before acting on that recommendation. This work is based on SEC filings, current events, interviews, corporate press releases, and what we've learned as financial journalists. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility.

DOD Featured Photos

Bridge Collapse Army Corps of Engineers staff observe the damage resulting from the collapse of the Francis Scott Ke... Photo Details > View All Photos

ABOUT   NEWS   HELP CENTER   PRESS PRODUCTS

Unsubscribe | Contact Us

This email was sent to stevenmagallanes520.nims@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Department of Defense 1400 Defense Pentagon Washington, DC 20301-1400